Page 226 - Read Online
P. 226

Page 18 of 20                 dos Santos et al. J Cancer Metastasis Treat 2019;5:25  I  http://dx.doi.org/10.20517/2394-4722.2018.83

               40.   van Straten D, Mashayekhi V, de Bruijn HS, Oliveira S, Robinson DJ. Oncologic photodynamic therapy: basic principles, current clinical
                   status and future directions. Cancers (Basel) 2017;9:1-54.
               41.   Kessel D. Death pathways associated with photodynamic therapy. Med Laser Appl 2006;21:219-24.
               42.   Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer
                   1972;26:239-57.
               43.   Tait SWG, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621-32.
               44.   Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, et al. XIAP discriminates between type i and type II FAS-induced apoptosis. Nature
                   2009;460:1035-9.
               45.   Shamas-Din A, Kale J, Leber B, Andrews DW. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol
                   2013;5:a008714.
               46.   Moldoveanu T, Follis AV, Kriwacki RW, Green DR. Many players in BCL-2 family affairs. Trends Biochem Sci 2014;39:101-11.
               47.   Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microb Cell 2016;3:101-8.
               48.   Huang K, Zhang J, O’Neill KL, Gurumurthy CB, Quadros RM, et al. Cleavage by caspase 8 and mitochondrial membrane association
                   activate the BH3-only protein bid during TRAIL-induced apoptosis. J Biol Chem 2016;291:11843-51.
               49.   Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev
                   Mol Cell Biol 2010;11:700-14.
               50.   Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008;27:6434-51.
               51.   Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic 2018;19:918-31.
               52.   Oliveira CS, Turchiello R, Kowaltowski AJ, Indig GL, Baptista MS. Major determinants of photoinduced cell death: subcellular localization
                   versus photosensitization efficiency. Free Radic Biol Med 2011;51:824-33.
               53.   Kessel D, Reiners JJ. Promotion of proapoptotic signals by lysosomal photodamage. Photochem Photobiol 2016;91:931-6.
               54.   Feng X, Shi Y, Xie L, Zhang K, Wang X, et al. Synthesis, characterization, and biological evaluation of a porphyrin-based photosensitizer
                   and its isomer for effective photodynamic therapy against breast cancer. J Med Chem 2018;61:7189-201.
               55.   Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J 2016;473:347-64.
               56.   Kushibiki T, Hirasawa T, Okawa S, Ishihara M. Responses of cancer cells induced by photodynamic therapy. J Healthc Eng 2013;4:87-108.
               57.   Reiners JJ, Agostinis P, Berg K, Oleinick NL, Kessel D. Assessing autophagy in the context of photodynamic therapy. Autophagy
                   2010;6:7-18.
               58.   Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nat Cell Biol 2014;16:728-36.
               59.   Coupienne I, Fettweis G, Rubio N, Agostinis P, Piette J. 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma. Photochem
                   Photobiol Sci 2011;10:1868-78.
               60.   Mrschtik M, Ryan KM. Lysosomal proteins in cell death and autophagy. FEBS J 2015;282:1858-70.
               61.   Zou J, Kawai T, Tsuchida T, Kozaki T, Tanaka H, et al. Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine
                   production and mediate dendritic cell necroptosis. Immunity 2013;38:717-28.
               62.   Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, et al. Ferroptosis : an iron-dependent form of nonapoptotic cell death. Cell
                   2012;149:1060-72.
               63.   Garg AD, Agostinis P. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.
                   Photochem Photobiol Sci 2014;13:474-87.
               64.   Acedo P, Stockert JC, Cañete M, Villanueva A. Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer.
                   Cell Death Dis 2014;5:e1122.
               65.   Tanaka M, Kataoka H, Yano S, Sawada T, Akashi H, et al. Immunogenic cell death due to a new photodynamic therapy (PDT) with
                   glycoconjugated chlorin (G-chlorin). Oncotarget 2016;7:47242-51.
               66.   Pizova K, Tomankova K, Daskova A, Binder S, Bajgar R, et al. Photodynamic therapy for enhancing antitumour immunity. Biomed Pap
                   Med Fac Univ Palacky Olomouc Czech Repub 2012;156:93-102.
               67.   Showalter A, Limaye A, Oyer JL, Igarashi R, Kittipatarin C, et al. Cytokines in immunogenic cell death: applications for cancer
                   immunotherapy. Cytokine 2017;97:123-32.
               68.   Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating
                   immunosurveillance. Immunity 2013;39:74-88.
               69.   Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
               70.   Garg AD, Maes H, Romano E, Agostinis P. Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity
                   responses following photodynamic therapy. Photochem Photobiol Sci 2015;14:1410-24.
               71.   Krysko D V, Garg AD, Kaczmarek A, Krysko O, Agostinis P, et al. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer
                   2012;12:860-75.
               72.   Inoue H, Tani K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ
                   2014;21:39-49.
               73.   Garg AD, Maes H, van Vliet AR, Agostinis P. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.
                   Mol Cell Oncol 2015;2:e975089.
               74.   Garg AD, Dudek AM, Agostinis P. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how? Biofactors 2013;39:355-67.
               75.   Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, et al. ROS-induced autophagy in cancer cells assists in evasion from
                   determinants of immunogenic cell death. Autophagy 2013;9:1292-307.
               76.   Shams M, Owczarczak B, Manderscheid-Kern P, Bellnier DA, Gollnick SO. Development of photodynamic therapy regimens that control
                   primary tumor growth and inhibit secondary disease. Cancer Immunol Immunother 2015;64:287-97.
               77.   Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, et al. Choice of oxygen-conserving treatment regimen determines the
                   inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 2004;64:2120-6.
   221   222   223   224   225   226   227   228   229   230   231